StonvexLoading…
StonvexStonvexStonvexCore line items from TASK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $306.27M | $1.18B | $870.59M | $571.88M |
Operating Income | $34.21M | $140.63M | $102.54M | $64.60M |
Net Income | $24.33M | $102.28M | $72.57M | $20.05M |
EPS (Diluted) | $0.26 | $1.10 | $0.78 | $0.44 |
Total Assets | $981.63M | $1.05B | $1.04B | $1.02B |
Total Liabilities | $706.67M | $450.78M | $469.85M | $473.73M |
Cash & Equivalents | $152.26M | $211.68M | $209.98M | $181.92M |
Free Cash Flow OCF − CapEx | $36.10M | $73.72M | $63.80M | $21.83M |
Shares Outstanding | 93.09M | 93.03M | 93.10M | 93.12M |